Literature DB >> 22450758

Both Sm-domain and C-terminal extension of Lsm1 are important for the RNA-binding activity of the Lsm1-7-Pat1 complex.

Ashis Chowdhury1, Kalidindi K Raju, Swathi Kalurupalle, Sundaresan Tharun.   

Abstract

Lsm proteins are a ubiquitous family of proteins characterized by the Sm-domain. They exist as hexa- or heptameric RNA-binding complexes and carry out RNA-related functions. The Sm-domain is thought to be sufficient for the RNA-binding activity of these proteins. The highly conserved eukaryotic Lsm1 through Lsm7 proteins are part of the cytoplasmic Lsm1-7-Pat1 complex, which is an activator of decapping in the conserved 5'-3' mRNA decay pathway. This complex also protects mRNA 3'-ends from trimming in vivo. Purified Lsm1-7-Pat1 complex is able to bind RNA in vitro and exhibits a unique binding preference for oligoadenylated RNA (over polyadenylated and unadenylated RNA). Lsm1 is a key subunit that determines the RNA-binding properties of this complex. The normal RNA-binding activity of this complex is crucial for mRNA decay and 3'-end protection in vivo and requires the intact Sm-domain of Lsm1. Here, we show that though necessary, the Sm-domain of Lsm1 is not sufficient for the normal RNA-binding ability of the Lsm1-7-Pat1 complex. Deletion of the C-terminal domain (CTD) of Lsm1 (while keeping the Sm-domain intact) impairs mRNA decay in vivo and results in Lsm1-7-Pat1 complexes that are severely impaired in RNA binding in vitro. Interestingly, the mRNA decay and 3'-end protection defects of such CTD-truncated lsm1 mutants could be suppressed in trans by overexpression of the CTD polypeptide. Thus, unlike most Sm-like proteins, Lsm1 uniquely requires both its Sm-domain and CTD for its normal RNA-binding function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450758      PMCID: PMC3334702          DOI: 10.1261/rna.029876.111

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  40 in total

1.  Crystal structure of a heptameric Sm-like protein complex from archaea: implications for the structure and evolution of snRNPs.

Authors:  B M Collins; S J Harrop; G D Kornfeld; I W Dawes; P M Curmi; B C Mabbutt
Journal:  J Mol Biol       Date:  2001-06-15       Impact factor: 5.469

2.  The crystal structure of a heptameric archaeal Sm protein: Implications for the eukaryotic snRNP core.

Authors:  C Mura; D Cascio; M R Sawaya; D S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

3.  A Sm-like protein complex that participates in mRNA degradation.

Authors:  E Bouveret; G Rigaut; A Shevchenko; M Wilm; B Séraphin
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

4.  The yeast cytoplasmic LsmI/Pat1p complex protects mRNA 3' termini from partial degradation.

Authors:  W He; R Parker
Journal:  Genetics       Date:  2001-08       Impact factor: 4.562

5.  The two proteins Pat1p (Mrt1p) and Spb8p interact in vivo, are required for mRNA decay, and are functionally linked to Pab1p.

Authors:  C Bonnerot; R Boeck; B Lapeyre
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  RNA binding in an Sm core domain: X-ray structure and functional analysis of an archaeal Sm protein complex.

Authors:  I Törö; S Thore; C Mayer; J Basquin; B Séraphin; D Suck
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

7.  The oligomerization and ligand-binding properties of Sm-like archaeal proteins (SmAPs).

Authors:  Cameron Mura; Anna Kozhukhovsky; Mari Gingery; Martin Phillips; David Eisenberg
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

8.  Structures of the pleiotropic translational regulator Hfq and an Hfq-RNA complex: a bacterial Sm-like protein.

Authors:  Maria A Schumacher; Robert F Pearson; Thorleif Møller; Poul Valentin-Hansen; Richard G Brennan
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

9.  The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci.

Authors:  Dierk Ingelfinger; Donna J Arndt-Jovin; Reinhard Lührmann; Tilmann Achsel
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

10.  The human Pat1b protein: a novel mRNA deadenylation factor identified by a new immunoprecipitation technique.

Authors:  Antonio Totaro; Fabrizio Renzi; Giorgio La Fata; Claudia Mattioli; Monika Raabe; Henning Urlaub; Tilmann Achsel
Journal:  Nucleic Acids Res       Date:  2010-09-17       Impact factor: 16.971

View more
  9 in total

Review 1.  Inhibition and avoidance of mRNA degradation by RNA viruses.

Authors:  Stephanie L Moon; Michael D Barnhart; Jeffrey Wilusz
Journal:  Curr Opin Microbiol       Date:  2012-05-23       Impact factor: 7.934

Review 2.  Determinants and implications of mRNA poly(A) tail size--does this protein make my tail look big?

Authors:  Aimee L Jalkanen; Stephen J Coleman; Jeffrey Wilusz
Journal:  Semin Cell Dev Biol       Date:  2014-06-05       Impact factor: 7.727

3.  Recognition of the small regulatory RNA RydC by the bacterial Hfq protein.

Authors:  Daniela Dimastrogiovanni; Kathrin S Fröhlich; Katarzyna J Bandyra; Heather A Bruce; Susann Hohensee; Jörg Vogel; Ben F Luisi
Journal:  Elife       Date:  2014-12-31       Impact factor: 8.140

4.  The Lsm1-7-Pat1 complex promotes viral RNA translation and replication by differential mechanisms.

Authors:  Jennifer Jungfleisch; Ashis Chowdhury; Isabel Alves-Rodrigues; Sundaresan Tharun; Juana Díez
Journal:  RNA       Date:  2015-06-19       Impact factor: 4.942

5.  Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models.

Authors:  Hyung-Jun Kim; Alya R Raphael; Eva S LaDow; Leeanne McGurk; Ross A Weber; John Q Trojanowski; Virginia M-Y Lee; Steven Finkbeiner; Aaron D Gitler; Nancy M Bonini
Journal:  Nat Genet       Date:  2013-12-15       Impact factor: 38.330

6.  Pat1 contributes to the RNA binding activity of the Lsm1-7-Pat1 complex.

Authors:  Ashis Chowdhury; Swathi Kalurupalle; Sundaresan Tharun
Journal:  RNA       Date:  2014-07-17       Impact factor: 4.942

7.  Mutagenic Analysis of the C-Terminal Extension of Lsm1.

Authors:  Ashis Chowdhury; Swathi Kalurupalle; Sundaresan Tharun
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

Review 8.  Lsm proteins and Hfq: Life at the 3' end.

Authors:  Carol J Wilusz; Jeffrey Wilusz
Journal:  RNA Biol       Date:  2013-02-07       Impact factor: 4.652

9.  Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma.

Authors:  Zijun Chen; Chuangye Han; Xin Zhou; Xiangkun Wang; Xiwen Liao; Yongfei He; Shutian Mo; Xuan Li; Guangzhi Zhu; Xinping Ye; Tao Peng
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.